EPA IRIS – Misryoum reports an EPA directive signals EPA offices may revisit hundreds of chemical toxicity assessments used in rules and permits.
A major EPA memo is putting long-standing chemical safety assessments under a cloud, raising the prospect that hundreds of environmental rules and permits could be weakened or unraveled.
The Integrated Risk Information System. known as IRIS. has served for decades as the agency’s central scientific reference point for estimating how toxic chemicals can be at different exposure levels.. Those assessments have been used across federal regulatory work. state decision-making. and even in countries that rely on U.S.-developed data rather than building their own.
In a directive circulated inside the agency. Misryoum reports that EPA leadership criticized the program’s approach and instructed offices that have used IRIS assessments to review them.. The memo also advised outside organizations that have relied on IRIS to consider similar reviews and warned against using the assessments in future regulatory efforts.
**Insight:** This matters because IRIS functions like infrastructure for chemical regulation. If the reference point is disputed, it can ripple outward into rules, permit standards, enforcement choices, and litigation strategy.
The EPA’s internal plan. as described by Misryoum. includes adding cautionary language to the IRIS website. signaling that IRIS findings are not intended to be treated as directly regulatory.. EPA officials also indicated in response to the controversy that the agency’s regulatory changes would still require the standard processes. including opportunities for public participation.
Misryoum notes that critics of IRIS—particularly those aligned with industry concerns—have long argued that the program’s assessments can be overly cautious and may drive higher compliance burdens than necessary.. Supporters and many environmental researchers. by contrast. have emphasized IRIS’s extensive review process and its role in providing detailed. science-based toxicity estimates intended to protect public health.
Meanwhile. Misryoum reports that lawmakers and advocacy groups have taken opposing positions over the years. including proposals aimed at restricting or eliminating the program’s influence in regulatory settings.. The controversy around IRIS has also existed alongside broader scrutiny from scientific reviewers. some of whom have urged changes while others have acknowledged improvements.
In this context. the latest directive arrives after years of turbulence around how the EPA conducts chemical science work. including internal staffing changes and disputes over which studies the agency will treat as authoritative.. Misryoum’s reporting also highlights that the administration’s approach appears to move from simply questioning aspects of the program to broadly instructing offices to revisit how IRIS information is applied.
**Insight:** Even without immediate, headline regulatory rollbacks, a shift in how risk assessments are treated can alter timelines and outcomes for ongoing permitting and enforcement, making it harder for the public to trust that the same health thresholds will govern everywhere.
For communities and regulated industries alike. the practical stakes are high: if IRIS assessments are reinterpreted or treated as less usable in rulemaking. standards tied to chemical toxicity data may face renewed challenges and delays.. Misryoum will continue tracking how the EPA implements the memo and whether state and federal agencies adjust their use of IRIS in upcoming regulatory actions.